The global market for Nifedipine Injection was valued at US$ 85.8 million in the year 2024 and is projected to reach a revised size of US$ 104 million by 2031, growing at a CAGR of 2.7% during the forecast period.

Nifedipine Injection Market

Nifedipine Injection is a calcium channel blocker (CCB) used primarily for the rapid reduction of blood pressure in hypertensive emergencies and certain cardiovascular conditions. It works by relaxing blood vessels and reducing cardiac workload, leading to improved blood flow and oxygen delivery.

North American market for Nifedipine Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Nifedipine Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Nifedipine Injection include Pfizer, Bayer, Pharmaoffer, Mylan, AdvaCare, Teva, Cisen Pharmaceutical, Wuhan Binhu Shuanghe Pharmaceutical, Medcalo, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Nifedipine Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nifedipine Injection.

The Nifedipine Injection market size, estimations, and forecasts are provided in terms of sales volume (L) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nifedipine Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Nifedipine Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Nifedipine Injection Market Report

Report Metric	Details
Report Name	Nifedipine Injection Market
Accounted market size in year	US$ 85.8 million
Forecasted market size in 2031	US$ 104 million
CAGR	2.7%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	10mg/2ml 20mg/2ml
Segment by Application	Hypertension Angina (Chest Pain)
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Pfizer, Bayer, Pharmaoffer, Mylan, AdvaCare, Teva, Cisen Pharmaceutical, Wuhan Binhu Shuanghe Pharmaceutical, Medcalo
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Nifedipine Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Nifedipine Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Nifedipine Injection Market growing?

Ans: The Nifedipine Injection Market witnessing a CAGR of 2.7% during the forecast period 2025-2031.

What is the Nifedipine Injection Market size in 2031?

Ans: The Nifedipine Injection Market size in 2031 will be US$ 104 million.

Who are the main players in the Nifedipine Injection Market report?

Ans: The main players in the Nifedipine Injection Market are Pfizer, Bayer, Pharmaoffer, Mylan, AdvaCare, Teva, Cisen Pharmaceutical, Wuhan Binhu Shuanghe Pharmaceutical, Medcalo

What are the Application segmentation covered in the Nifedipine Injection Market report?

Ans: The Applications covered in the Nifedipine Injection Market report are Hypertension, Angina (Chest Pain)

What are the Type segmentation covered in the Nifedipine Injection Market report?

Ans: The Types covered in the Nifedipine Injection Market report are 10mg/2ml, 20mg/2ml

1 Nifedipine Injection Market Overview

1.1 Product Definition

1.2 Nifedipine Injection by Type

1.2.1 Global Nifedipine Injection Market Value Comparison by Type (2024 VS 2031)

1.2.2 10mg/2ml

1.2.3 20mg/2ml

1.3 Nifedipine Injection by Application

1.3.1 Global Nifedipine Injection Market Value by Application (2024 VS 2031)

1.3.2 Hypertension

1.3.3 Angina (Chest Pain)

1.4 Global Nifedipine Injection Market Size Estimates and Forecasts

1.4.1 Global Nifedipine Injection Revenue 2020-2031

1.4.2 Global Nifedipine Injection Sales 2020-2031

1.4.3 Global Nifedipine Injection Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Nifedipine Injection Market Competition by Manufacturers

2.1 Global Nifedipine Injection Sales Market Share by Manufacturers (2020-2025)

2.2 Global Nifedipine Injection Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Nifedipine Injection Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Nifedipine Injection, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Nifedipine Injection, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Nifedipine Injection, Product Type & Application

2.7 Global Key Manufacturers of Nifedipine Injection, Date of Enter into This Industry

2.8 Global Nifedipine Injection Market Competitive Situation and Trends

2.8.1 Global Nifedipine Injection Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Nifedipine Injection Players Market Share by Revenue

2.8.3 Global Nifedipine Injection Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Nifedipine Injection Market Scenario by Region

3.1 Global Nifedipine Injection Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Nifedipine Injection Sales by Region: 2020-2031

3.2.1 Global Nifedipine Injection Sales by Region: 2020-2025

3.2.2 Global Nifedipine Injection Sales by Region: 2026-2031

3.3 Global Nifedipine Injection Revenue by Region: 2020-2031

3.3.1 Global Nifedipine Injection Revenue by Region: 2020-2025

3.3.2 Global Nifedipine Injection Revenue by Region: 2026-2031

3.4 North America Nifedipine Injection Market Facts & Figures by Country

3.4.1 North America Nifedipine Injection Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Nifedipine Injection Sales by Country (2020-2031)

3.4.3 North America Nifedipine Injection Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Nifedipine Injection Market Facts & Figures by Country

3.5.1 Europe Nifedipine Injection Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Nifedipine Injection Sales by Country (2020-2031)

3.5.3 Europe Nifedipine Injection Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Nifedipine Injection Market Facts & Figures by Region

3.6.1 Asia Pacific Nifedipine Injection Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Nifedipine Injection Sales by Region (2020-2031)

3.6.3 Asia Pacific Nifedipine Injection Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Nifedipine Injection Market Facts & Figures by Country

3.7.1 Latin America Nifedipine Injection Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Nifedipine Injection Sales by Country (2020-2031)

3.7.3 Latin America Nifedipine Injection Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Nifedipine Injection Market Facts & Figures by Country

3.8.1 Middle East and Africa Nifedipine Injection Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Nifedipine Injection Sales by Country (2020-2031)

3.8.3 Middle East and Africa Nifedipine Injection Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Nifedipine Injection Sales by Type (2020-2031)

4.1.1 Global Nifedipine Injection Sales by Type (2020-2025)

4.1.2 Global Nifedipine Injection Sales by Type (2026-2031)

4.1.3 Global Nifedipine Injection Sales Market Share by Type (2020-2031)

4.2 Global Nifedipine Injection Revenue by Type (2020-2031)

4.2.1 Global Nifedipine Injection Revenue by Type (2020-2025)

4.2.2 Global Nifedipine Injection Revenue by Type (2026-2031)

4.2.3 Global Nifedipine Injection Revenue Market Share by Type (2020-2031)

4.3 Global Nifedipine Injection Price by Type (2020-2031)

5 Segment by Application

5.1 Global Nifedipine Injection Sales by Application (2020-2031)

5.1.1 Global Nifedipine Injection Sales by Application (2020-2025)

5.1.2 Global Nifedipine Injection Sales by Application (2026-2031)

5.1.3 Global Nifedipine Injection Sales Market Share by Application (2020-2031)

5.2 Global Nifedipine Injection Revenue by Application (2020-2031)

5.2.1 Global Nifedipine Injection Revenue by Application (2020-2025)

5.2.2 Global Nifedipine Injection Revenue by Application (2026-2031)

5.2.3 Global Nifedipine Injection Revenue Market Share by Application (2020-2031)

5.3 Global Nifedipine Injection Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Pfizer

6.1.1 Pfizer Company Information

6.1.2 Pfizer Description and Business Overview

6.1.3 Pfizer Nifedipine Injection Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Pfizer Nifedipine Injection Product Portfolio

6.1.5 Pfizer Recent Developments/Updates

6.2 Bayer

6.2.1 Bayer Company Information

6.2.2 Bayer Description and Business Overview

6.2.3 Bayer Nifedipine Injection Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Bayer Nifedipine Injection Product Portfolio

6.2.5 Bayer Recent Developments/Updates

6.3 Pharmaoffer

6.3.1 Pharmaoffer Company Information

6.3.2 Pharmaoffer Description and Business Overview

6.3.3 Pharmaoffer Nifedipine Injection Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Pharmaoffer Nifedipine Injection Product Portfolio

6.3.5 Pharmaoffer Recent Developments/Updates

6.4 Mylan

6.4.1 Mylan Company Information

6.4.2 Mylan Description and Business Overview

6.4.3 Mylan Nifedipine Injection Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Mylan Nifedipine Injection Product Portfolio

6.4.5 Mylan Recent Developments/Updates

6.5 AdvaCare

6.5.1 AdvaCare Company Information

6.5.2 AdvaCare Description and Business Overview

6.5.3 AdvaCare Nifedipine Injection Sales, Revenue and Gross Margin (2020-2025)

6.5.4 AdvaCare Nifedipine Injection Product Portfolio

6.5.5 AdvaCare Recent Developments/Updates

6.6 Teva

6.6.1 Teva Company Information

6.6.2 Teva Description and Business Overview

6.6.3 Teva Nifedipine Injection Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Teva Nifedipine Injection Product Portfolio

6.6.5 Teva Recent Developments/Updates

6.7 Cisen Pharmaceutical

6.7.1 Cisen Pharmaceutical Company Information

6.7.2 Cisen Pharmaceutical Description and Business Overview

6.7.3 Cisen Pharmaceutical Nifedipine Injection Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Cisen Pharmaceutical Nifedipine Injection Product Portfolio

6.7.5 Cisen Pharmaceutical Recent Developments/Updates

6.8 Wuhan Binhu Shuanghe Pharmaceutical

6.8.1 Wuhan Binhu Shuanghe Pharmaceutical Company Information

6.8.2 Wuhan Binhu Shuanghe Pharmaceutical Description and Business Overview

6.8.3 Wuhan Binhu Shuanghe Pharmaceutical Nifedipine Injection Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Wuhan Binhu Shuanghe Pharmaceutical Nifedipine Injection Product Portfolio

6.8.5 Wuhan Binhu Shuanghe Pharmaceutical Recent Developments/Updates

6.9 Medcalo

6.9.1 Medcalo Company Information

6.9.2 Medcalo Description and Business Overview

6.9.3 Medcalo Nifedipine Injection Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Medcalo Nifedipine Injection Product Portfolio

6.9.5 Medcalo Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Nifedipine Injection Industry Chain Analysis

7.2 Nifedipine Injection Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Nifedipine Injection Production Mode & Process Analysis

7.4 Nifedipine Injection Sales and Marketing

7.4.1 Nifedipine Injection Sales Channels

7.4.2 Nifedipine Injection Distributors

7.5 Nifedipine Injection Customer Analysis

8 Nifedipine Injection Market Dynamics

8.1 Nifedipine Injection Industry Trends

8.2 Nifedipine Injection Market Drivers

8.3 Nifedipine Injection Market Challenges

8.4 Nifedipine Injection Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Wuhan Binhu Shuanghe Pharmaceutical

Medcalo

List of Tables

Table 1. Global Nifedipine Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Nifedipine Injection Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Nifedipine Injection Market Competitive Situation by Manufacturers in 2024

Table 4. Global Nifedipine Injection Sales (L) of Key Manufacturers (2020-2025)

Table 5. Global Nifedipine Injection Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Nifedipine Injection Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Nifedipine Injection Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Nifedipine Injection Average Price (US$/mL) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Nifedipine Injection, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Nifedipine Injection, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Nifedipine Injection, Product Type & Application

Table 12. Global Key Manufacturers of Nifedipine Injection, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Nifedipine Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nifedipine Injection as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Nifedipine Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Nifedipine Injection Sales by Region (2020-2025) & (L)

Table 18. Global Nifedipine Injection Sales Market Share by Region (2020-2025)

Table 19. Global Nifedipine Injection Sales by Region (2026-2031) & (L)

Table 20. Global Nifedipine Injection Sales Market Share by Region (2026-2031)

Table 21. Global Nifedipine Injection Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Nifedipine Injection Revenue Market Share by Region (2020-2025)

Table 23. Global Nifedipine Injection Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Nifedipine Injection Revenue Market Share by Region (2026-2031)

Table 25. North America Nifedipine Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Nifedipine Injection Sales by Country (2020-2025) & (L)

Table 27. North America Nifedipine Injection Sales by Country (2026-2031) & (L)

Table 28. North America Nifedipine Injection Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Nifedipine Injection Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Nifedipine Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Nifedipine Injection Sales by Country (2020-2025) & (L)

Table 32. Europe Nifedipine Injection Sales by Country (2026-2031) & (L)

Table 33. Europe Nifedipine Injection Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Nifedipine Injection Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Nifedipine Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Nifedipine Injection Sales by Region (2020-2025) & (L)

Table 37. Asia Pacific Nifedipine Injection Sales by Region (2026-2031) & (L)

Table 38. Asia Pacific Nifedipine Injection Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Nifedipine Injection Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Nifedipine Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Nifedipine Injection Sales by Country (2020-2025) & (L)

Table 42. Latin America Nifedipine Injection Sales by Country (2026-2031) & (L)

Table 43. Latin America Nifedipine Injection Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Nifedipine Injection Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Nifedipine Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Nifedipine Injection Sales by Country (2020-2025) & (L)

Table 47. Middle East and Africa Nifedipine Injection Sales by Country (2026-2031) & (L)

Table 48. Middle East and Africa Nifedipine Injection Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Nifedipine Injection Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Nifedipine Injection Sales (L) by Type (2020-2025)

Table 51. Global Nifedipine Injection Sales (L) by Type (2026-2031)

Table 52. Global Nifedipine Injection Sales Market Share by Type (2020-2025)

Table 53. Global Nifedipine Injection Sales Market Share by Type (2026-2031)

Table 54. Global Nifedipine Injection Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Nifedipine Injection Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Nifedipine Injection Revenue Market Share by Type (2020-2025)

Table 57. Global Nifedipine Injection Revenue Market Share by Type (2026-2031)

Table 58. Global Nifedipine Injection Price (US$/mL) by Type (2020-2025)

Table 59. Global Nifedipine Injection Price (US$/mL) by Type (2026-2031)

Table 60. Global Nifedipine Injection Sales (L) by Application (2020-2025)

Table 61. Global Nifedipine Injection Sales (L) by Application (2026-2031)

Table 62. Global Nifedipine Injection Sales Market Share by Application (2020-2025)

Table 63. Global Nifedipine Injection Sales Market Share by Application (2026-2031)

Table 64. Global Nifedipine Injection Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Nifedipine Injection Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Nifedipine Injection Revenue Market Share by Application (2020-2025)

Table 67. Global Nifedipine Injection Revenue Market Share by Application (2026-2031)

Table 68. Global Nifedipine Injection Price (US$/mL) by Application (2020-2025)

Table 69. Global Nifedipine Injection Price (US$/mL) by Application (2026-2031)

Table 70. Pfizer Company Information

Table 71. Pfizer Description and Business Overview

Table 72. Pfizer Nifedipine Injection Sales (L), Revenue (US$ Million), Price (US$/mL) and Gross Margin (2020-2025)

Table 73. Pfizer Nifedipine Injection Product

Table 74. Pfizer Recent Developments/Updates

Table 75. Bayer Company Information

Table 76. Bayer Description and Business Overview

Table 77. Bayer Nifedipine Injection Sales (L), Revenue (US$ Million), Price (US$/mL) and Gross Margin (2020-2025)

Table 78. Bayer Nifedipine Injection Product

Table 79. Bayer Recent Developments/Updates

Table 80. Pharmaoffer Company Information

Table 81. Pharmaoffer Description and Business Overview

Table 82. Pharmaoffer Nifedipine Injection Sales (L), Revenue (US$ Million), Price (US$/mL) and Gross Margin (2020-2025)

Table 83. Pharmaoffer Nifedipine Injection Product

Table 84. Pharmaoffer Recent Developments/Updates

Table 85. Mylan Company Information

Table 86. Mylan Description and Business Overview

Table 87. Mylan Nifedipine Injection Sales (L), Revenue (US$ Million), Price (US$/mL) and Gross Margin (2020-2025)

Table 88. Mylan Nifedipine Injection Product

Table 89. Mylan Recent Developments/Updates

Table 90. AdvaCare Company Information

Table 91. AdvaCare Description and Business Overview

Table 92. AdvaCare Nifedipine Injection Sales (L), Revenue (US$ Million), Price (US$/mL) and Gross Margin (2020-2025)

Table 93. AdvaCare Nifedipine Injection Product

Table 94. AdvaCare Recent Developments/Updates

Table 95. Teva Company Information

Table 96. Teva Description and Business Overview

Table 97. Teva Nifedipine Injection Sales (L), Revenue (US$ Million), Price (US$/mL) and Gross Margin (2020-2025)

Table 98. Teva Nifedipine Injection Product

Table 99. Teva Recent Developments/Updates

Table 100. Cisen Pharmaceutical Company Information

Table 101. Cisen Pharmaceutical Description and Business Overview

Table 102. Cisen Pharmaceutical Nifedipine Injection Sales (L), Revenue (US$ Million), Price (US$/mL) and Gross Margin (2020-2025)

Table 103. Cisen Pharmaceutical Nifedipine Injection Product

Table 104. Cisen Pharmaceutical Recent Developments/Updates

Table 105. Wuhan Binhu Shuanghe Pharmaceutical Company Information

Table 106. Wuhan Binhu Shuanghe Pharmaceutical Description and Business Overview

Table 107. Wuhan Binhu Shuanghe Pharmaceutical Nifedipine Injection Sales (L), Revenue (US$ Million), Price (US$/mL) and Gross Margin (2020-2025)

Table 108. Wuhan Binhu Shuanghe Pharmaceutical Nifedipine Injection Product

Table 109. Wuhan Binhu Shuanghe Pharmaceutical Recent Developments/Updates

Table 110. Medcalo Company Information

Table 111. Medcalo Description and Business Overview

Table 112. Medcalo Nifedipine Injection Sales (L), Revenue (US$ Million), Price (US$/mL) and Gross Margin (2020-2025)

Table 113. Medcalo Nifedipine Injection Product

Table 114. Medcalo Recent Developments/Updates

Table 115. Key Raw Materials Lists

Table 116. Raw Materials Key Suppliers Lists

Table 117. Nifedipine Injection Distributors List

Table 118. Nifedipine Injection Customers List

Table 119. Nifedipine Injection Market Trends

Table 120. Nifedipine Injection Market Drivers

Table 121. Nifedipine Injection Market Challenges

Table 122. Nifedipine Injection Market Restraints

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

Table 126. Authors List of This Report

List of Figures

Figure 1. Product Picture of Nifedipine Injection

Figure 2. Global Nifedipine Injection Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Nifedipine Injection Market Share by Type: 2024 & 2031

Figure 4. 10mg/2ml Product Picture

Figure 5. 20mg/2ml Product Picture

Figure 6. Global Nifedipine Injection Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Nifedipine Injection Market Share by Application: 2024 & 2031

Figure 8. Hypertension

Figure 9. Angina (Chest Pain)

Figure 10. Global Nifedipine Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 11. Global Nifedipine Injection Market Size (2020-2031) & (US$ Million)

Figure 12. Global Nifedipine Injection Sales (2020-2031) & (L)

Figure 13. Global Nifedipine Injection Average Price (US$/mL) & (2020-2031)

Figure 14. Nifedipine Injection Report Years Considered

Figure 15. Nifedipine Injection Sales Share by Manufacturers in 2024

Figure 16. Global Nifedipine Injection Revenue Share by Manufacturers in 2024

Figure 17. Global 5 and 10 Largest Nifedipine Injection Players: Market Share by Revenue in Nifedipine Injection in 2024

Figure 18. Nifedipine Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 19. Global Nifedipine Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 20. North America Nifedipine Injection Sales Market Share by Country (2020-2031)

Figure 21. North America Nifedipine Injection Revenue Market Share by Country (2020-2031)

Figure 22. United States Nifedipine Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 23. Canada Nifedipine Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Europe Nifedipine Injection Sales Market Share by Country (2020-2031)

Figure 25. Europe Nifedipine Injection Revenue Market Share by Country (2020-2031)

Figure 26. Germany Nifedipine Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. France Nifedipine Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. U.K. Nifedipine Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. Italy Nifedipine Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Russia Nifedipine Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Asia Pacific Nifedipine Injection Sales Market Share by Region (2020-2031)

Figure 32. Asia Pacific Nifedipine Injection Revenue Market Share by Region (2020-2031)

Figure 33. China Nifedipine Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Japan Nifedipine Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. South Korea Nifedipine Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. India Nifedipine Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Australia Nifedipine Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. China Taiwan Nifedipine Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Southeast Asia Nifedipine Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Latin America Nifedipine Injection Sales Market Share by Country (2020-2031)

Figure 41. Latin America Nifedipine Injection Revenue Market Share by Country (2020-2031)

Figure 42. Mexico Nifedipine Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Brazil Nifedipine Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Argentina Nifedipine Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Colombia Nifedipine Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Middle East and Africa Nifedipine Injection Sales Market Share by Country (2020-2031)

Figure 47. Middle East and Africa Nifedipine Injection Revenue Market Share by Country (2020-2031)

Figure 48. Turkey Nifedipine Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Saudi Arabia Nifedipine Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. UAE Nifedipine Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Global Sales Market Share of Nifedipine Injection by Type (2020-2031)

Figure 52. Global Revenue Market Share of Nifedipine Injection by Type (2020-2031)

Figure 53. Global Nifedipine Injection Price (US$/mL) by Type (2020-2031)

Figure 54. Global Sales Market Share of Nifedipine Injection by Application (2020-2031)

Figure 55. Global Revenue Market Share of Nifedipine Injection by Application (2020-2031)

Figure 56. Global Nifedipine Injection Price (US$/mL) by Application (2020-2031)

Figure 57. Nifedipine Injection Value Chain

Figure 58. Channels of Distribution (Direct Vs Distribution)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions